HS code · 6-digit subheading
HS Code 3002.14 – Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, mixed, put up in measured doses or in forms or packings for retail sale
HS code 3002.14 is the 6-digit subheading for blood, human or animal, antisera, other blood fractions and immunological products, immunological products, mixed, put up in measured doses or in forms or packings for retail sale. It is used for mixed monoclonal antibody cocktails (e.g., for cancer), immunoglobulin preparations (mixed, retail), cytokine therapy combinations, interferon combination therapies and diagnostic kits containing mixed immunological reagents (for retail).
What HS 3002.14 covers
This specific HS code covers immunological products that are already mixed and prepared in measured doses or packaged for retail sale, but are *not* vaccines. These are typically finished biopharmaceutical products designed for direct therapeutic or prophylactic use, often requiring a prescription. The trade involves highly specialized and high-value medicines, such as combination antibody therapies or complex immunomodulators. Importers are usually national healthcare systems, pharmaceutical distributors, hospitals, and pharmacies, while exporters are major global pharmaceutical companies with extensive R&D and manufacturing capabilities. The market is characterized by stringent regulatory approval processes, patent protection, and significant investment in research. Logistics involve precise temperature control and secure distribution channels to maintain product integrity and prevent counterfeiting.
- Covers
- Mixed monoclonal antibody cocktails (e.g., for cancer)
- Immunoglobulin preparations (mixed, retail)
- Cytokine therapy combinations
- Interferon combination therapies
- Diagnostic kits containing mixed immunological reagents (for retail)
- Allergen extracts for immunotherapy (mixed, retail)
- Immunosuppressants (biological, mixed, retail)
- Examples
- Dupixent (dupilumab, for asthma/eczema)
- Keytruda (pembrolizumab, for cancer - if mixed formulation)
- Stelara (ustekinumab, for psoriasis/Crohn's)
- Humira (adalimumab - if mixed formulation)
- Enbrel (etanercept - if mixed formulation)
- Remicade (infliximab - if mixed formulation)
Codes often confused with 3002.14
Common mistake. This code is distinct from 300215 because it specifically refers to *mixed* immunological products, whereas 300215 covers *unmixed* immunological products in retail packaging. It is also separate from vaccines (300241/300242).
Top exporters and importers of HS code 300214, 2025
In 2025, the largest exporter of HS code 300214 in UN Comtrade data was the United States, with 26% of world exports; the largest importer in UN Comtrade data was the United States, with 32% of world imports. Countries that did not report 2025 data are estimated from partner records, which can understate them.
Top exporters 2025 · share of world exports
- 1 United States $10.3B 26% of world exports
- 2 Ireland $8.8B 22% of world exports
- 3 Switzerland $6.2B 16% of world exports
World total: $39.8B Reported figures on UN Comtrade ↗
Top importers 2025 · share of world imports
- 1 United States $12.8B 32% of world imports
- 2 Germany $5.7B 14% of world imports
- 3 Switzerland $4.4B 11% of world imports
World total: $40.5B Reported figures on UN Comtrade ↗
How these figures are built
109 countries reported 2025 trade to UN Comtrade in HS 2022, and their own totals are used. Countries that did not report are estimated from what other countries recorded trading with them. Those estimates miss trade with other non-reporting countries, so they can be low, and a non-reporting country can rank higher than shown or be missing from the list. World totals add both and leave out trade between two non-reporting countries. Figures are in current US dollars; reported imports are mostly valued CIF and exports FOB, and exports include re-exports. The UN Comtrade links show the underlying records; they can also list a few reporters left out here (regional groups and older HS editions).
Source: UN Comtrade (United Nations Statistics Division), 2025 annual data.
Brazil NCM code for 3002.14
Brazil does not split HS 3002.14: its NCM code is 3002.14.00.
All Brazil NCM codes in heading 30.02 →
Source: Siscomex NCM table, updated Oct 2026. The Portuguese text is official; the English is our translation.
Questions about HS 3002.14
What is HS code 300214?
HS code 300214 is a 6-digit subheading in the Harmonized System that covers: Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, mixed, put up in measured doses or in forms or packings for retail sale. This specific HS code covers immunological products that are already mixed and prepared in measured doses or packaged for retail sale, but are *not* vaccines. These are typically finished biopharmaceutical products designed for direct therapeutic or prophylactic use, often requiring a prescription. The trade involves highly specialized and high-value medicines, such as combination antibody therapies or complex immunomodulators. Importers are usually national healthcare systems, pharmaceutical distributors, hospitals, and pharmacies, while exporters are major global pharmaceutical companies with extensive R&D and manufacturing capabilities. The market is characterized by stringent regulatory approval processes, patent protection, and significant investment in research. Logistics involve precise temperature control and secure distribution channels to maintain product integrity and prevent counterfeiting.
What products fall under HS code 300214?
Mixed monoclonal antibody cocktails (e.g., for cancer), Immunoglobulin preparations (mixed, retail), Cytokine therapy combinations, Interferon combination therapies, Diagnostic kits containing mixed immunological reagents (for retail), Allergen extracts for immunotherapy (mixed, retail), Immunosuppressants (biological, mixed, retail)
What are common misclassifications for HS code 300214?
This code is distinct from 300215 because it specifically refers to *mixed* immunological products, whereas 300215 covers *unmixed* immunological products in retail packaging. It is also separate from vaccines (300241/300242).
Which countries are the top exporters of goods under HS code 300214?
In 2025, the top exporters of HS code 300214 in UN Comtrade data were the United States ($10.3B, 26% of world exports), Ireland ($8.8B) and Switzerland ($6.2B). World exports came to about $39.8B, adding countries' reported figures and partner-based estimates for those that did not report (UN Comtrade data). Countries that did not report 2025 data are estimated from partner records, which can understate them.
Which countries are the top importers of goods under HS code 300214?
In 2025, the top importers of HS code 300214 in UN Comtrade data were the United States ($12.8B, 32% of world imports), Germany ($5.7B) and Switzerland ($4.4B). World imports came to about $40.5B, adding countries' reported figures and partner-based estimates for those that did not report (UN Comtrade data). Countries that did not report 2025 data are estimated from partner records, which can understate them.
How is HS code 300214 structured?
HS code 300214 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (02) identify the heading, and digits 5-6 (14) specify the subheading. This code is standardized globally by the World Customs Organization.
What is the Brazil NCM code for HS code 300214?
In Brazil, HS code 300214 is NCM 3002.14.00. The last two digits are 00 because Brazil does not split this HS code further.